Xeltis announces completion of enrolment in EU Pivotal Trial for aXess and prepares for market approval ...Middle East

- Enrolment completed - 120 patients with end-stage renal disease in 22 centers in Europe - Primary endpoint readouts anticipated in Q2 2025, first market approval expected in 2026 - Capability to obtain market approval is further strengthened with the appointment of Rob Eyers as Chief...

Hence then, the article about xeltis announces completion of enrolment in eu pivotal trial for axess and prepares for market approval was published today ( Tuesday 07/01/2025 - 11:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Xeltis announces completion of enrolment in EU Pivotal Trial for aXess and prepares for market approval )

Also on site :

• Travel Warning Issued For Millions Across US
• ‘Change is inevitable’: What is next for Iran?
• Australian Open: Sinner overcomes cramps; Keys, Pegula advance; Osaka withdraws